Some unspecified error has occurred.

Professor Chris Abell

November 11, 1957 - October 26, 2020

Professor Chris Abell FRS FMedsci was Pro-Vice Chancellor for Research, and Professor of Biological Chemistry at the University of Cambridge. A biological chemist, he was an undergraduate and postgraduate at Cambridge, before doing postdoctoral research at Brown University, USA. Chris was admitted as a Fellow of Christ's College in 1986. He led research teams in the Department of Chemistry pioneering the use of fragment-based approaches in drug discovery and developing microdroplets as an experimental platform. Chris cofounded Astex, Sphere Fluidics and Aqdot, and was a founding director of Cambridge Enterprise. From 2013-2015 Chris was the first Director of Postdoctoral Affairs at the University.

More... Less...

  • Memories Memories
    One moment please, your post is being saved...
  • Image Image
    To attach an image drag & drop it here or
    One moment please, your post is being saved...
  • Video Video
    Upload a video on YouTube and paste the code here:
    One moment please, your post is being saved...
  • Condolences Condolences
  • Condolences Condolences
    One moment please, your post is being saved...

2020-10-28 14:59:15 wrote:

On behalf of Hughes Hall our sincere condolences to Chris' family and friends. His leadership on behalf of post-docs made a lasting difference to the University and our College, while his good humour and diligence in his role as PVC, not only leading the REF but also dealing with Brexit and the most recent COVID testing initiatives are a testament to his impact that complements his exceptional success in science and business.

2020-10-28 14:59:15 wrote: On behalf of Hughes Hall our sincere condolences to Chris' family and friends. His leadership on behalf of post-docs made a lasting difference to the University and our College, while his good humour and diligence in his role as PVC, not only leading the REF but also dealing with Brexit and the most recent COVID testing initiatives are a testament to his impact that complements his exceptional success in science and business.

Comments (0)

  • No comments.